Brind.

Teva plans to launch Austedo in European markets and partnered with Sanofi for duvakitug.

1 report, 1 independent Updated Jul 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Teva plans to launch Austedo in European markets and partnered with Sanofi for duvakitug.

Who's involved

What this event is mainly about
SanofiTeva Pharmaceutical Industries Ltd.

How it developed

Newest first. Tap a step to see who reported it.
  1. Teva partners with Sanofi for Duvakitug development.Sub-event
  2. Teva and Sanofi announced a partnership and Teva plans a European launch.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksTEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock? Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has s